| Title |
Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study
|
|---|---|
| Published in |
Journal of Inflammation Research, July 2021
|
| DOI | 10.2147/jir.s322645 |
| Pubmed ID | |
| Authors |
Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Magdalena Rogalska, Diana Martonik, Paweł Pabjan, Aleksandra Berkan-Kawińska, Beata Bolewska, Barbara Oczko-Grzesik, Dorota Kozielewicz, Magdalena Tudrujek-Zdunek, Justyna Kowalska, Anna Moniuszko-Malinowska, Krzysztof Kłos, Marta Rorat, Piotr Leszczyński, Anna Piekarska, Joanna Polańska, Robert Flisiak |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 25% |
| Spain | 1 | 25% |
| United States | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 49 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 18% |
| Student > Bachelor | 4 | 8% |
| Lecturer | 2 | 4% |
| Other | 2 | 4% |
| Researcher | 2 | 4% |
| Other | 5 | 10% |
| Unknown | 25 | 51% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 27% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
| Agricultural and Biological Sciences | 2 | 4% |
| Biochemistry, Genetics and Molecular Biology | 1 | 2% |
| Nursing and Health Professions | 1 | 2% |
| Other | 3 | 6% |
| Unknown | 27 | 55% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2021.
All research outputs
#5,689,152
of 23,308,124 outputs
Outputs from Journal of Inflammation Research
#124
of 828 outputs
Outputs of similar age
#117,812
of 442,548 outputs
Outputs of similar age from Journal of Inflammation Research
#11
of 82 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 828 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,548 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.